Pantoham in the treatment of patients with organic brain lesions of different genesis

Rogacheva T.A.; Melnikova T.S.; Krasnoslobodtseva L.A.; Nazmetdinova D.M.; Lapin I.A.

doi:https://doi.org/

Rogacheva T.A.

klinika ékzogenno-organicheskikh rasstroĭstv i épilepsii

Melnikova T.S.

Moskovskiĭ NII psikhiatrii Roszdrava

Krasnoslobodtseva L.A.

Kafedra psikhiatrii fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Nazmetdinova D.M.

Otdelenie ékzogenno-organicheskikh rasstroĭstv i épilepsii Moskovskogo NII psikhiatrii

Lapin I.A.

Moskovskiĭ NII psikhiatrii Roszdrava

Pantoham in the treatment of patients with organic brain lesions of different genesis

Authors:

Rogacheva T.A., Melnikova T.S., Krasnoslobodtseva L.A., Nazmetdinova D.M., Lapin I.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(10): 34‑39

Read: 6569 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Rogacheva TA, Melnikova TS, Krasnoslobodtseva LA, Nazmetdinova DM, Lapin IA. Pantoham in the treatment of patients with organic brain lesions of different genesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(10):34‑39. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90

The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104

Cognitive impairment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

Impaired time perception in attention deficit hyperactivity disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):55-61

Characteristics, treatment features and in-hospital mortality of patients with myocardial infarction over 75 years old in Russia according to the REGION-IM registry. Russian Cardiology Bulletin. 2025;(1):22-38

Chronic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medicine. 2025;(2):5-16

Community-acquired pneumonia in adults. Clinical guidelines 2024 (short version). Journal of Respiratory Medicine. 2025;(3):6-18

Abstract:

We studied 35 patients with organic brain lesions caused by secondary brain harmful factors (group 1) and 33 patients with organic brain diseases of vascular genesis (group 2). Mean age of patients was 45.5±2.3 years. Asthenic, cerebroasthenic, psychoorganic syndromes in the combination with dissomnic, psychoautonomous, depressive, hypochondriac disorders predominated in the clinical picture of patients. Pantoham was prescribed in dose 1.0 g 3 times daily during 45 days. The effect of the drug on cognitive and mental disorders was found. The drug was most effective in patients of group 1. Pantoham was well-tolerated.

Keywords:

organic brain diseases

therapy

nootropics

pantogam

Authors:

Rogacheva T.A.

klinika ékzogenno-organicheskikh rasstroĭstv i épilepsii

Melnikova T.S.

Moskovskiĭ NII psikhiatrii Roszdrava

Krasnoslobodtseva L.A.

Kafedra psikhiatrii fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Nazmetdinova D.M.

Otdelenie ékzogenno-organicheskikh rasstroĭstv i épilepsii Moskovskogo NII psikhiatrii

Lapin I.A.

Moskovskiĭ NII psikhiatrii Roszdrava

Close metadata

References:

Avedisova A.S.Osobennosti psikhofarmakoterapii u bol'nykh s pogranichnymi psikhicheskimi rasstroistvami. M 1998.
Avedisova A.S. i dr.Analiz zarubezhnykh issledovanii nootropnykh preparatov (na primere piratsetama). Ros psikhiat zhurn 2001;1:46-54.
Avrutskii G.Ya., Niss A.I.Klinicheskie aspekty terapii nootropnymi preparatami. Farmakologiya nootropov (eksperimental'noe i klinicheskoe izuchenie). M 1989;112-118.
Ben'kovich B.I., Faizulloev A.Z. Vliyanie pikamilona i pantogama na mekhanizmy pamyati i vnimaniya u bol'nykh s nevroticheskimi i nevrozopodobnymi rasstroistvami. Pikamilon v sovremennoi psikhiatricheskoi i nevrologicheskoi praktike. M 1994.
Voronina T.A. Farmakologiya nootropov. M 1989;8-19.
Voronina T.A. i dr.Nootropnye i anksioliticheskie svoistva raznykh doz piratsetama. Eksperimental'naya i klinicheskaya farmakologiya. M 2000;2:9-11.
Zhirmunskaya E.A.Klinicheskaya elektroentsefalografiya (tsifry, gistogrammy, illyustratsii). M 1993;35.
Kovalev G.V., Muzychenko A.P.Primenenie nootropnykh sredstv v psikhiatrii i narkologii. Nootropnye sredstva. Volgograd 1990;217-294.
Kovler M.A. i dr.Farmakologicheskie svoistva i klinicheskoe primenenie neirobutala - novogo rossiiskogo nootropnogo preparata (analiz dannykh nevrologicheskikh i psikhiatricheskikh klinik). Sots i klin psikhiat 1998;3:68-72.
Krasnov V.N., Yurkin M.M., Voitsekh V.F. i dr.Psikhicheskie rasstroistva u uchastnikov likvidatsii posledstvii avarii na Chernobyl'skoi AES. Sots i klin psikhiat 1993;1.
Krasnov V.N., Muzychenko A.P.Novyi neirometabolicheskii tserebroprotektor idebinon: perspektivy primeneniya v psikhiatrii. Sots i klin psikhiat 2000;1:61-63.
Mosolov S.N.Sovremennye tendentsii razvitiya psikhofarmakologii. Zhurn nevrol i psikhiat 1998;5:12-19.
Petrov V.I., Ozerov A.A.Sravnitel'naya nootropnaya aktivnost' pikamilona, pantogama i novykh analogov mediatornykh aminokislot. Pikamilon v sovremennoi nevrologicheskoi i psikhiatricheskoi praktike. M 1994;42-49.
Plotnikov M.B. i dr.Itogi razrabotki novykh tserebroprotektorov dlya lecheniya narushenii mozgovogo krovoobrashcheniya. Materialy konferentsii, posvyashchennoi 15-letiyu NII farmakologii. Tomsk 1999;10:78-87.
Rogacheva T.A., Mel'nikova T.S., Lubsanova S.V.Nooklerin v korrektsii astenicheskikh rasstroistv u bol'nykh epilepsiei. S''ezd psikhiatrov Rossii, 14-i:Materialy. M 2005;247.
Rogacheva T.A., Mel'nikova T.S., Krasnoslobodtseva L.A.Dinamika elektroentsefalograficheskikh parametrov u bol'nykh s organicheskim porazheniem golovnogo mozga pod vliyaniem neirometabolicheskikh stimulyatorov. Zhurn psikhiatr 2008;108:1:1-6.
Sapegin I.D., Beketov A.I.Vliyanie pikamilona i fenibuta na krovosnabzhenie golovnogo mozga v usloviyakh pokoya i pri gravitatsionnykh vozdeistviyakh. Zhurn eksper i klin farmakol 1993;1:28-31.